蔡 牧宏

Medicine & Life Sciences

1. Survival 100%
2. Chemoradiotherapy 92%
3. Radiotherapy 67%
4. Head and Neck Neoplasms 57%
5. Fluorodeoxyglucose F18 56%
6. Squamous Cell Carcinoma 52%
7. Radiation 50%
8. Neck 42%
9. Nasopharyngeal Neoplasms 41%
10. Adjuvant Chemoradiotherapy 40%
11. Hypopharyngeal Neoplasms 39%
12. Neoplasms 39%
13. Anaplastic Thyroid Carcinoma 37%
14. Registries 34%
15. Nomograms 32%
16. Mouth 31%
17. Adjuvant Chemotherapy 30%
18. Squamous Cell Carcinoma of Head and Neck 29%
19. Mouth Neoplasms 29%
20. Positron Emission Tomography Computed Tomography 29%
21. Lymph Nodes 28%
22. Endometrial Neoplasms 27%
23. pembrolizumab 26%
24. Thyroid Gland 25%
25. Immunotherapy 23%
26. Databases 22%
27. Lymphocytes 21%
28. Lung Neoplasms 21%
29. Confidence Intervals 20%
30. Spine 20%
31. Therapeutics 20%
32. Bone and Bones 19%
33. Histology 13%
34. Nasopharyngeal Carcinoma 13%
35. Population 12%
36. Serum 12%
37. Drug Therapy 11%
38. Radiation Oncologists 11%
39. Osteoradionecrosis 9%
40. Head 9%
41. Reconstructive Surgical Procedures 7%
42. Oncologists 7%